These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 5762992)
1. [Therapy of primary hyperlipemias]. Schlierf G; Kahlke W Dtsch Med Wochenschr; 1969 Feb; 94(7):329-32. PubMed ID: 5762992 [No Abstract] [Full Text] [Related]
2. Control of biochemical precursors of coronary heart disease. Ostrander LD Geriatrics; 1969 Dec; 24(12):61-6. PubMed ID: 5353631 [No Abstract] [Full Text] [Related]
3. Treatment of hyperlipidemic states. Strisower EH; Adamson G; Strisower B Med Clin North Am; 1970 Nov; 54(6):1599-613. PubMed ID: 5487683 [No Abstract] [Full Text] [Related]
4. Diet and drug therapy for hyperlipoproteinemia. Maha GE Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828 [No Abstract] [Full Text] [Related]
5. [Therapy of primary hyperlipemia]. Schneider J; Kaffarnik H Dtsch Med Wochenschr; 1971 May; 96(19):831-2. PubMed ID: 5574353 [No Abstract] [Full Text] [Related]
12. Treatment of hypercholesteremia and hypertriglyceridemia. Albrink MJ JAMA; 1969 Jan; 207(4):763. PubMed ID: 5818205 [No Abstract] [Full Text] [Related]
13. Management of the hyperlipidemic patient. Berkowitz D Med Clin North Am; 1973 Jul; 57(4):881-92. PubMed ID: 4576152 [No Abstract] [Full Text] [Related]
14. Divergent effects in the treatment of hyperlipemia. Slowe IA; Carter AC; Feldman EB Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355 [No Abstract] [Full Text] [Related]
16. Measures to reduce the serum lipid levels in coronary heart disease. Connor WE Med Clin North Am; 1968 Sep; 52(5):1249-60. PubMed ID: 4876837 [No Abstract] [Full Text] [Related]
17. [Therapeutic orientation in the hyperlipidemias]. Forti N; Diament J; Giannini SD Arq Bras Cardiol; 1979 Sep; 33(3):207-15. PubMed ID: 396911 [No Abstract] [Full Text] [Related]
18. [Hyperlipemias]. Guerre J Sem Hop; 1965 Oct; 41(44):2536-8. PubMed ID: 4285197 [No Abstract] [Full Text] [Related]
19. Physiological rationale for differential drug therapy. Levy RI Postgrad Med J; 1975; 51(8):60-2. PubMed ID: 1221380 [No Abstract] [Full Text] [Related]
20. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia]. De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027 [No Abstract] [Full Text] [Related] [Next] [New Search]